| TC | Stat | Stk | Ins | Fil | +d | +w | +m | +q | +h | +y | avg | 
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 4 | 1 | 8 | 7 | 40 | 70 | 135 | 43 | 
| S | %wins | 25 | 0 | 25 | 0 | 0 | 0 | 8 | 
| Filing Date | T Date | Ticker | Issuer | Inc | Sector | Ind | Industry | Owner | oSt | Rel | Title | T | TVal | Price | L | Qty | oc | Own | H | r2y | r1y | r6m | r3m | r6w | r3w | r7d | r3d | f1d | f1w | f1m | f3m | f6m | f1y | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/8/13 19:17 | 11/6/13 | PCRX | Pacira Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Markvicka Taunia | NJ | O | VP,Comme | S.d | -2,557 | 51.14 | 23 | -50 | -100 | 0 | D | 519 | 212 | 69 | 34 | 1 | -12 | -4 | -9 | 1 | 7 | -2 | 26 | 54 | 72 | 
| 9/27/13 18:11 | 9/25/13 | PCRX | Pacira Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Markvicka Taunia | NJ | O | VP,Comme | S.d | -470 | 47.00 | 17 | -10 | -100 | 0 | D | 355 | 155 | 64 | 66 | 31 | 29 | 16 | 14 | 1 | 11 | 4 | 20 | 33 | 107 | 
| 8/16/13 16:29 | 8/14/13 | PCRX | Pacira Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Markvicka Taunia | NJ | O | VP,Comme | S.d | -544 | 37.00 | 12 | -15 | -100 | 0 | D | 302 | 132 | 83 | 24 | 17 | 4 | -1 | 1 | 0 | 2 | 13 | 51 | 88 | 185 | 
| 7/15/13 10:53 | 7/12/13 | PCRX | Pacira Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Markvicka Taunia | NJ | O | VP,Comme | S.d | -952 | 32.00 | 15 | -30 | -100 | 0 | D | 180 | 108 | 72 | 7 | 9 | 8 | 7 | 5 | 3 | 10 | 11 | 64 | 105 | 176 | 
| D | Derivative transaction in filing (usually option exercise) | 
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price | 
| A | Amended filing | 
| E | Error detected in filing | 
| S - Sale | Sale of securities on an exchange or to another person | 
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) | 
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company | 
| P - Purchase | Purchase of securities on an exchange or from another person |